Deenz Psychopathy Spectrum Scale (DPSS)
normative dataset currently contains
3179
participant records collected between
Jun 11, 2026
and
Nov 13, 2026
.
This psychometric dataset currently includes 3179 anonymous participant responses collected through voluntary participation. The observed mean score was 51.95 with a standard deviation of 16.29, indicating moderate score variability within the sampled population. Internal consistency reliability analysis demonstrated good reliability (Cronbach alpha = 0.84). Observed skewness (-0.1) and kurtosis (-0.39) were examined as indicators of distribution quality. The score distribution appeared reasonably balanced and did not suggest substantial departures from normality.
3179
Participants
100
Countries
24
Scale Items
0.84
Reliability
Table 1
Dataset Overview
Assessment
Deenz Psychopathy Spectrum Scale (DPSS)
Research Status
Robust Dataset
Dataset Maturity
95
/100 —
ROBUST
Participants
3179
Countries Represented
100
Items
24
Dimensions
6
Data Collection Period
Jun 11, 2026
–
Nov 13, 2026
Reliability
α =
0.84
Note.
The current Deenz Psychopathy Spectrum Scale (DPSS) dataset contains 3179 participant records collected from 100 countries. Dataset maturity reflects sample size, geographic diversity, and internal consistency reliability.
Table 2
Descriptive Statistics
Statistic
Value
Mean Score
51.95%
Median Score
52
Standard Deviation
16.29
Variance
265.53
Standard Error
0.29
95% CI Lower
51.39
95% CI Upper
52.52
Minimum Score
0%
Maximum Score
95%
Observed Range
95
Note.
M = 51.95, SD = 16.29, Median = 52. The 95% confidence interval ranged from 51.39 to 52.52.
Table 3
Sample Characteristics
Variable
Summary
Participants
N =
3179
Countries
100
Age Information
Available
Gender Information
Available
Note.
Demographic information was collected voluntarily. Participant counts may vary across demographic categories when information was not reported.
Age Distribution
Age Group
Participants
18-24
823
under18
795
25-34
472
35-44
201
prefer_not
192
45-54
103
55plus
61
Gender Distribution
Gender
Participants
Female
1296
Male
1237
Prefer_not
114
Figure 1
Global Participation
Note.
Participants were represented across 100 countries. The largest contribution originated from BR (40.5% of available geographic records).
Country
Participants
Percent
BR
1287
40.5%
FR
447
14.1%
US
292
9.2%
IN
151
4.7%
DE
143
4.5%
ES
115
3.6%
GB
48
1.5%
NL
47
1.5%
MX
37
1.2%
CA
31
1%
AU
29
0.9%
PT
26
0.8%
PH
19
0.6%
UA
17
0.5%
RU
17
0.5%
PE
17
0.5%
CL
17
0.5%
T1
16
0.5%
AT
16
0.5%
BE
16
0.5%
IT
15
0.5%
VE
15
0.5%
AR
14
0.4%
FI
14
0.4%
CH
14
0.4%
SE
14
0.4%
PL
14
0.4%
CO
13
0.4%
LV
11
0.3%
ID
11
0.3%
IE
10
0.3%
SV
10
0.3%
KZ
10
0.3%
EC
10
0.3%
DZ
10
0.3%
BY
9
0.3%
GT
7
0.2%
CZ
7
0.2%
DK
7
0.2%
HU
7
0.2%
AE
7
0.2%
GE
6
0.2%
BO
6
0.2%
CU
6
0.2%
VN
6
0.2%
SG
6
0.2%
EE
6
0.2%
DO
6
0.2%
PY
6
0.2%
MA
6
0.2%
GR
5
0.2%
SK
5
0.2%
ZA
4
0.1%
NO
4
0.1%
AO
4
0.1%
JP
4
0.1%
TH
4
0.1%
CN
4
0.1%
TR
4
0.1%
TG
3
0.1%
SA
3
0.1%
EG
3
0.1%
HR
3
0.1%
MG
3
0.1%
ML
3
0.1%
RO
3
0.1%
IL
3
0.1%
RS
2
0.1%
BG
2
0.1%
MD
2
0.1%
KG
2
0.1%
NC
2
0.1%
TJ
2
0.1%
BA
2
0.1%
PA
2
0.1%
CI
2
0.1%
LT
2
0.1%
LK
2
0.1%
TN
2
0.1%
UZ
2
0.1%
MN
1
0%
CG
1
0%
UY
1
0%
AL
1
0%
BJ
1
0%
MV
1
0%
AM
1
0%
IS
1
0%
KR
1
0%
HK
1
0%
PF
1
0%
KE
1
0%
MT
1
0%
HN
1
0%
NP
1
0%
CM
1
0%
JO
1
0%
SN
1
0%
RE
1
0%
MM
1
0%
Table 4
Percentile Norms
Percentile
Score
Interpretation
10th
30%
Very Low
25th
41%
Below Average
50th
52%
Average
75th
64%
Above Average
90th
74%
Elevated
Note.
Percentile values provide preliminary normative benchmarks derived from the current Deenz Psychopathy Spectrum Scale (DPSS) sample.
Figure 2
Score Distribution
Note.
Observed scores ranged from 0% to 95% (M = 51.95, SD = 16.29). Distribution characteristics included skewness (-0.1) and kurtosis (-0.39).
Distribution indices suggested no substantial departures from normality.
Table 5
Reliability Analysis
Metric
Value
Cronbach Alpha
0.84
Reliability Classification
Good
Participants
3179
Items
24
Standard Error
0.29
Note.
Internal consistency was estimated using Cronbach alpha. Reliability estimates are based on the current normative dataset and may change as additional responses are collected.
Item–Total Correlations
Item Analysis Interpretation
Item–total correlations were generally strong across the assessment, indicating that most items contribute effectively to the measurement of the underlying construct.
The analysis identified6
itemsthat may benefit from future review.
Items Recommended for Future Review
Q1
(r = -0.14)
I am able to resolve conflicts in a peaceful manner.
Q2
(r = -0.16)
I am the type of person who tries my best to avoid making threatening language or aggressive statements.
Q19
(r = 0.13)
If I compare myself to others, these comparisons make me feel worse about myself.
Q21
(r = 0.13)
I always maintain my composure and remain calm even in stressful situations.
Q22
(r = -0.03)
I lack the ability to attract and influence others.
Q24
(r = 0.19)
I often lose interest when listening to someone talk about their problems.
The lowest item–total correlation was observed for Q2 ("I am the type of person who tries my best to avoid making threatening language or aggressive statements."; r = -0.15), indicating comparatively weaker alignment with the overall construct.
Table 7
Dimension Norms
Dimension
Mean
SD
N
Callousness
62.08%
25.28
3179
Manipulation
58.29%
26.2
3179
Impulsivity
54.59%
25.79
3179
Ego
54.16%
17.29
3179
Aggression
45.99%
22.18
3179
Glibness
37.58%
14.51
3179
Note.
Dimension statistics summarize normative performance across the major constructs measured by Deenz Psychopathy Spectrum Scale (DPSS).
Figure 5
Dimension Profile
Note.
The highest observed dimension was Callousness (62.1%), whereas the lowest observed dimension was Glibness (37.6%). The observed difference between dimensions was 24.5 percentage points. Substantial variation was observed between dimensions.
Table 8
Dataset Growth Summary
Metric
Value
Current Participants
3179
Countries
100
Collection Start
Jun 11, 2026
Collection End
Nov 13, 2026
Months Recorded
6
Note.
Growth statistics summarize cumulative participation throughout the observed data collection period.
Normative Data Notice
A total of
3179
participant responses were available for this assessment.
Dimension-level norms were calculated using
3179
valid response records.
Approximately
0
response record(s) were excluded from dimension-level normative calculations due to incomplete response patterns.
Limitations
Normative statistics are derived from voluntary participation and may not represent all populations. Reliability estimates, percentile norms, and dimension statistics should be interpreted in the context of the current sample and may change as additional responses are collected.
Ethical Statement
All records included in this dataset were collected anonymously. No personally identifying information is stored. Data are intended for educational, psychometric, and research purposes.
Recommended Citation
Deenz Psychopathy Spectrum Scale (DPSS). Research Dataset. Retrieved from https://drdeenz.com/psychopathy-spectrum-test/statistics/